NO882237L - Fremgangsmaate for fremstilling av nye anf-derivater. - Google Patents

Fremgangsmaate for fremstilling av nye anf-derivater.

Info

Publication number
NO882237L
NO882237L NO882237A NO882237A NO882237L NO 882237 L NO882237 L NO 882237L NO 882237 A NO882237 A NO 882237A NO 882237 A NO882237 A NO 882237A NO 882237 L NO882237 L NO 882237L
Authority
NO
Norway
Prior art keywords
procedure
preparation
new
anf
derivatives
Prior art date
Application number
NO882237A
Other languages
English (en)
Norwegian (no)
Other versions
NO882237D0 (no
Inventor
Judd M Berman
Chester F Hassman Iii
John T Pelton
Stephen H Buck
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO882237D0 publication Critical patent/NO882237D0/no
Publication of NO882237L publication Critical patent/NO882237L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO882237A 1987-05-21 1988-05-20 Fremgangsmaate for fremstilling av nye anf-derivater. NO882237L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5316687A 1987-05-21 1987-05-21
US15106088A 1988-02-01 1988-02-01

Publications (2)

Publication Number Publication Date
NO882237D0 NO882237D0 (no) 1988-05-20
NO882237L true NO882237L (no) 1988-11-22

Family

ID=26731524

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882237A NO882237L (no) 1987-05-21 1988-05-20 Fremgangsmaate for fremstilling av nye anf-derivater.

Country Status (12)

Country Link
EP (1) EP0291999A3 (ja)
JP (1) JPS63303998A (ja)
KR (1) KR880013975A (ja)
CN (1) CN88103014A (ja)
AU (1) AU608847B2 (ja)
DK (1) DK278688A (ja)
FI (1) FI882361A (ja)
HU (1) HU199877B (ja)
IL (1) IL86386A0 (ja)
NO (1) NO882237L (ja)
NZ (1) NZ224660A (ja)
PT (1) PT87535B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565606A (en) * 1986-10-21 1996-10-15 Hoechst Aktiengesellschaft Synthesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method
DE3723551A1 (de) * 1987-07-16 1989-01-26 Hoechst Ag Peptide mit vasorelaxierender, natriuretischer und diuretischer wirkung, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
DK167813B1 (da) * 1989-12-07 1993-12-20 Carlbiotech Ltd As Pentapeptidderivat, farmaceutisk acceptable salte heraf, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
US5364884A (en) * 1993-01-21 1994-11-15 Baylor College Of Medicine Arginine compounds as ocular hypotensive agents
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5846932A (en) * 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
CN1062311C (zh) * 1996-12-27 2001-02-21 中国医学科学院基础医学研究所 人白细胞介素2衍生物与人心钠素衍生物的融合基因、其蛋白产物及应用
KR20000064848A (ko) * 1997-02-05 2000-11-06 도리이 신이치로 심장 비대에 기인하는 심장병 치료용 의약 조성물
JP5355383B2 (ja) 2006-03-30 2013-11-27 パラティン・テクノロジーズ・インコーポレーテッド 環状ナトリウム利尿ペプチド構築物
US8580746B2 (en) 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
WO2007115182A2 (en) 2006-03-30 2007-10-11 Palatin Technologies, Inc. Linear natriuretic peptide constructs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA846084B (en) * 1983-08-29 1985-05-29 Montreal Inst Rech Cliniques Natriuretic factors
JPS61286400A (ja) * 1985-06-14 1986-12-16 Ajinomoto Co Inc 新規ペプチド
JPS61197597A (ja) * 1985-02-27 1986-09-01 Sankyo Co Ltd 合成ペプチド
EP0271041A3 (en) * 1986-12-10 1990-04-11 Abbott Laboratories Atrial peptide derivatives

Also Published As

Publication number Publication date
NO882237D0 (no) 1988-05-20
FI882361A (fi) 1988-11-22
PT87535B (pt) 1992-10-30
FI882361A0 (fi) 1988-05-19
EP0291999A2 (en) 1988-11-23
KR880013975A (ko) 1988-12-22
HUT47134A (en) 1989-01-30
HU199877B (en) 1990-03-28
AU608847B2 (en) 1991-04-18
PT87535A (pt) 1989-05-31
CN88103014A (zh) 1988-12-14
DK278688A (da) 1988-11-22
NZ224660A (en) 1990-12-21
DK278688D0 (da) 1988-05-20
JPS63303998A (ja) 1988-12-12
EP0291999A3 (en) 1990-07-11
AU1634688A (en) 1988-11-24
IL86386A0 (en) 1988-11-15

Similar Documents

Publication Publication Date Title
NO873091L (no) Fremgangsmaate for fremstilling av nye benzimidazolderivater.
NO892936D0 (no) Fremgangsmaate for fremstilling av furanderivater.
NO880452L (no) Fremgangsmaate for fremstilling av nye polyaminderivater.
NO904059D0 (no) Fremgangsmaate for fremstilling av nye substituerte isokinoliner.
NO882237L (no) Fremgangsmaate for fremstilling av nye anf-derivater.
NO880910D0 (no) Fremgangsmaate for fremstilling av chromonderivater.
NO901813L (no) Fremgangsmaate for fremstilling av nye tieno-triazolo-diazepin-derivater.
NO903043D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO891588L (no) Fremgangsmaate for fremstilling av fosfonoalkylpurinderivater.
NO883145D0 (no) Fremgangsmaate til fremstilling av tienoimidazolderivater.
NO903207D0 (no) Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
NO892977L (no) Fremgangsmaate for fremstilling av nye s-adenosylmethionin-derivater.
NO884900D0 (no) Fremgangsmaate for fremstilling av ginkolid-derivater.
NO854577L (no) Fremgangsmaate for fremstilling av nye tienopyridinderivater.
NO904069L (no) Fremgangsmaate for fremstilling av nye alkanofenoner.
NO872393D0 (no) Fremgangsmaate for fremstilling av nye aralkylimidazolderivater.
NO902762D0 (no) Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater.
NO871721L (no) Fremgangsmaate for fremstilling av nye ergolenderivater.
NO883398D0 (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
NO883610D0 (no) Fremgangsmaate til fremstilling av substituerte tienoimidazol-derivater.
NO901687L (no) Fremgangsmaate for fremstilling av thiazetokinolin-3-karboksylsyrederivater.
NO903967D0 (no) Fremgangsmaate for fremstilling av dihydrocaffeinsyrederivater.
NO894707L (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
NO884100L (no) Fremgangsmaate for fremstilling av halogentiazolderivater.
NO884901L (no) Fremgangsmaate for fremstilling av nye indenofuran-derivater.